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Adipose tissue is an easy, accessible, and abundant source of mesenchymal stem cells (MSCs) for the recon-
struction and addition of soft tissue and for restoration of soft-tissue defects associated with trauma, tumor
resections, and congenital deformities. A stable source of adipose cells or tissue is needed for autologous grafting.
Therefore, the aim of this study was to obtain enough autologous adipose tissue for possible clinical applications.
For this purpose, we isolated MSCs (CD34+=CD90+) from human lipoaspirated or resected fat, which differen-
tiated into adipocytes when placed in culture. Human adipose tissue is a paramount source of autologous MSCs
were capable of generating a complete adipose tissue in vitro. Differentiated adipocytes expressed a strong po-
sitivity for several specific antibodies, including adiponectin and peroxisome proliferator-activated receptor
gamma. In addition, fibroblasts (*10% of the whole sorted-cell population) started to secrete an extracellular
matrix after 60 days that was strongly positive for type I collagen and fibronectin. After long-term culture (4
months), an adipose tissue with collagenic fibers and vessels was obtained. This tissue was comparable with
adult human adipose tissue and therefore may be a criterion standard for future tissue repair and regeneration
and for therapeutic and transplantation purposes.
Introduction
Mesenchymal stem cells (MSCs) are an excellentsource for adipose tissue engineering.1 Soft tissue is
necessary for reconstructive and plastic surgery. The com-
mon clinical approach is to restore defects using free mi-
crovascular flaps and transferring adipose tissue grafts made
of different alloplastic and allogenic products. In recent years,
transplantation of autologous adipose tissue has been used
for correction of soft-tissue defects, including trauma, tumor
resection, and congenital and acquired anomalies, but au-
tologous fat transplantation has unsatisfactory long-term
results.2,3 Limitations of this method are due to mature adi-
pocyte fragility, as well as to insufficient or unsuitable vascu-
larization. Fat grafts are reabsorbed and replaced by fibrous
tissue with formation of liponecrotic cysts.4,5 Moreover, cells
located centrally within fat grafting undergo tissue necrosis,
with volume loss and inflammation due to vascular failure.6
Stem and precursor adipose cells have been used for
in vitro experiments, where they proliferate and differentiate;7
moreover, they are capable of differentiating in vivo.8 How-
ever, stem and precursor adipose cells have high long-term
survival.9,10 For efficient adipose tissue regeneration, specific
cell selection is necessary. Human adipose tissue–derived
adult stem cells (hADASCs) have been previously identi-
fied;11 these stem cells display multilineage developmen-
tal plasticity in vitro and in vivo. Furthermore, pools of
hADASCs can be induced to express the biochemical profile
of adipocytes, chondrocytes, and osteoblasts under appro-
priate in vitro culture conditions.12,13 In culture, these cells
express cell-surface markers similar to those expressed by
MSCs, including CD105, STRO-1, CD90, and CD44, and
share many features with MSCs.14 Several researches have
carried out adipose tissue engineering using the 3T3-L1
murine preadipose cell line,15 rat preadipocytes,16 or bone
marrow–derived MSCs.17 The interest raised in adipose
tissue as a source of adult multipotent stem cells has
also generated results for their use in regenerative medi-
cine;18 adipose tissue is an abundant and practical
source of precursor cells for soft-tissue reconstruction. This
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stem cell population displays a high capability for self-
expansion and differentiation into preadipocytes.
In this study, we isolated and selected hADASCs, which
have several features that differ with respect to those pre-
viously discussed, mainly regarding their ability to produce a
vascularized autologous adipose tissue. This tissue is suitable
for clinical regeneration, transplantation, and implantation.
Materials and Methods
Adipose tissue extraction and digestion
Subcutaneous adipose tissue of abdominal and mammary
originwasobtainedwith informedconsent fromfemalepatients
aged 18 to 43 who had undergone elective procedures for
plastic surgery. Adipose tissue was obtained by lipectomy or
liposuction in the Plastic and Reconstructive Surgery Clinic of
the SecondUniversity ofNaples. The adipose tissuewas placed
in a physiological solution (sodium chloride (NaCl) 0.9%),
washed twice in phosphate buffered saline (PBS) 1 (137mM
NaCl, 2.7mMpotassiumchloride, 10mMdisodiumphosphate,
1.8mM monopotassium phosphate), scraped, and placed in a
digestion solution (collagenase type I (3mg=mL) and dispase
(4mg=mL), supplemented with penicillin (100U=mL), strep-
tomycin (100mg=mL) and clarythromicin (500mg=mL)) in PBS
1 at 378C in agitation for 60min The digest was filtered
through 70-mm filters (Becton & Dickinson, Sunnyvale, CA).
Cell culture
After filtration and washing, the pellet was resuspended
in erythrocyte lysis buffer (155mM ammonium chloride;
10mM potassium bicarbonate, 0.1mM ethylenediaminete-
traacetic acid (EDTA), pH 7.3) for 10min at room tempera-
ture. The cell suspension was centrifuged at 1300 rpm for
7min and the pellet resuspended in 5mL of Dulbecco’s
modified Eaglemedium with 10% fetal bovine serum (FBS),
2mM L-glutamine, 100U=mL penicillin, and 100 mg=mL
streptomycin and seeded in 25-cm2 flasks. Flasks were in-
cubated at 378C with 5% carbon dioxide and the medium
changed twice a week. Cells reached confluence in 5 to 7 days.
Experiments were performed in quadruplicate.
In vitro differentiation
We studied three methods of stimulation of adipose differ-
entiation: basal culture medium supplemented with 20% FBS
for the whole experiment;19,20 culture medium supplemented
with 10% FBS plus dexamethasone (1mM, Sigma, Milan, Italy),
human recombinant insulin (10mM, Sigma), indomethacin
(200mM, Fluka, Milan, Italy), and 3-isobutyl-1-methyl-xantine
(IBMX) (0.5mM, Sigma); and hADASCs cocultured with
sorted fibroblasts (10%) and grown in basal culture me-
dium supplemented with 20% FBS for 4 months. The media
were changed two times per week. Cells cultured in a basal
medium without additions were used as controls.
Limited dilution assay and proliferative
potential of hADASc
To assess clonogenic and proliferative ability of cells, a sus-
pension of hADASCs (CD34þ=CD90þ=CD45–)was diluted and
single cells seeded in multiwells. Two weeks later, cells were
stained with Toluidine blue to assess their proliferation rate.
Flow cytometry
Cells were detached using a solution of trypsin-EDTA
(200mg=L EDTA, 500mg=L trypsin, Cambrex, Verviers,
Belgium). At least 200,000 cells were incubated with primary
antibody for 30min at 48C, washed twice in PBS 1, and
incubated with a secondary antibody. Alternatively, cells
were incubated directly with fluorescent-conjugated anti-
bodies for 30min at 48C, washed, and resuspended in 0.6mL
PBS 1. Samples were analyzed at day 0 (day of withdrawal),
day 15, and day 30. Antibodies used in this study were anti-
CD117 phycoerythrin (PE) (c-kit) (Miltenyi -Biotech, Cal-
derara di Reno, Italy), anti-CD34 fluorescein isothiocyanate
(FITC) and PE (Miltenyi-Biotech), anti-CD90 FITC (Chemi-
con, Prodotti Gianni, Milan, Italy), anti-CD105 FITC (Saint,
Santa Cruz, CA), anti-CD29 Cy (Miltenyi-Biotech), anti-
CD31 FITC (Miltenyi-Biotech), anti-CD133 PE (Miltenyi-
Biotech), anti-human vascular endothelial growth factor
(hVEGF); Santa Cruz Biotechnology, Santa Cruz, CA), anti-
VEGF receptor 2 (VEGFR-2; Santa Cruz Biotechnology), anti-
CD54 PE (Miltenyi-Biotech), anti-CD44 FITC (Miltenyi-Bio-
tech), anti-CD45 Cy and PE (Becton & Dickinson, Franklin
Lakes, NJ), and anti-CD14 PE (Miltenyi-Biotech).
A FACS Vantage (Becton Dickinson) was used, and data
were analyzed using CellQuest Software (Becton Dickinson).
Immunofluorescence and Immunohistochemical
staining
Cells in multiwells were washed in PBS 1and fixed with
4% paraformaldehyde for 30min at 48C, washed three times
in PBS 1 for 10min, and incubated in PBS\5% FBS for
60min at 48C. After another double washing in PBS 1 for
10min at room temperature, cells were incubated overnight
at 48C with monoclonal antihuman antibodies (diluted 1:100
in PBS 1). Wells were washed in PBS 1 three times for
10min at room temperature and incubated for 90min at 48C
with the secondary FITC- or PE-conjugated antibody (di-
luted 1:200 in PBS 1) (Santa Cruz Biotechnology). These cells
were also treated with 40, 6-diamidino-2-phenylindole) (In-
vitrogen, San Giuliano Milanese, Italy) diluted 1:10000
(5 mg=mL) in PBS 1 for 7min at room temperature. Cells
incubated for 90min at 48C with conjugated secondary an-
tibodies were used as negative control. Cells were then ob-
served under a fluorescence microscope (Nikon Instruments
Italia, Calenzano, Italy).
Immunohistochemical analyses were performed using a
DAKO CYTOMATION kit (En Visionþ System-HRP-AEC,
Dako Italia, Milan, Italy) according to the manufacturer’s
protocol.
RNA isolation and polymerase chain reaction
RNAwas extracted using TRI Reagent (Sigma,Milan, Italy).
cDNA synthesis was carried on total RNA using SuperScript
II reverse transcriptase (Invitrogen, San Giuliano Milanese,
Italy). Primer sequences used were glyceraldehyde-3-
phosphate dehydrogenase: fw AGCCGCATCTTCTTTTGC
GTC; rw TCATATTTGGCAGGTTTTTCT; CD34: fw AAA
GACCCTGATTGCACTGG rw GCCCTGAGTCAATTTCA
CTT; CD90: fw CCCAGTGAAGATGCAGGTTT; rw GAC
AGCCTGAGAGGGTCTTG; CD44: fw TCCAAAGGTTTT
CCATCCTG; rw AGGGCCAGCCTCTATGAAAT; CD54: fw
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CAGGTTGTAACACTGCAGGAGAG; rw ATTGTGAACAC
TGGCAGAAATG; VEGF: fw TGACAGGGAAGAGGAGGA
GA; rw CGTCTGACCTGGGGTAGAGA.
Results
Stem cell isolation was performed using enzymatic di-
gestion as described in the Materials and Methods section,
and three different methods of differentiation were used and
compared. By day 1, cells cultured in medium supplemented
with 20% FBS were adherent and quickly expanding; they
exhibited an elongated fibroblast-like morphology (Fig. 1A).
Confluence was obtained after 5 to 7 days. When hADASCs
were cultured in the medium containing adipogenic-
inducing factors (insulin, dexamethasone, and IBMX), ap-
proximately 80% of the cells differentiated into adipocytes
containing multilocular lipid droplets within the cytoplasm
(Fig. 1B). These adipocytes were strongly positive for adi-
ponectin (Fig. 1C). Undifferentiated cells were negative (Fig.
1D). To assess the proliferation rate and the clonogenic po-
tential of cells, we performed a limiting dilution assay. After
2 week of culture, most wells (16=24), which had been ini-
tially plated with one cell each, contained colonies with a
doubling time of approximately 5 days (showing high clo-
nogenic capability). After 7 days of culture, the proliferation
rate of CD34þ cells was higher than that of CD34– cells (82%),
as shown by Ki-67 expression (Fig. 2A). The proliferation rate
of CD34– cells was low (18%) or negligible (Fig. 2B). Cell
cycle events can be distinguished based on the expression of
Ki-67. Cells in S phase or G2=M phase are Ki-67
þ (Fig. 2C).
Using the FACSorter, we analyzed 1000,000 100,000 cell
samples using specific stem-cell antigens (see below). At
day 0, we detected three stem or progenitor cell populations:
stromal stem cells that coexpressed CD117 (5%) and CD34
(7%); mesenchymal stem or progenitor cells, whose markers
were CD29 (b1-integrin) (72%), CD34 (25%), CD90 (Thy-1)
FIG. 1. (A) Human adipose tissue–derived adult stem cells
(hADASCs) in 20% fetal bovine serum–supplemented me-
dium at day 1 exhibit an elongated fibroblast-like morphol-
ogy (original magnification,200). (B) hADASCs in medium
containing adipogenic inducing factors differentiate into adi-
pocytes with lipid droplets (arrow) (original magnification,
400). (C) Adipocytes stained with adiponectin (arrow) (orig-
inal magnification,400). (D) Undifferentiated cells, showing
negativity for adiponectin (original magnification,200).
FIG. 2. (A) Proliferation rate of CD34þ at day 7. (B) Proliferation rate of CD34– at days 7. (C) Cell cycle of CD34þ cells.
(D) Cell cycle of CD34– cells.
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(30%), and CD105 (endoglin) (5%); and endothelial stem or
progenitor cells, whose markers were CD31 (6%), CD133
(8%), CD44=CD54 (5%), and Flk-1 (VEGFR-2) (45%) (Fig. 3).
Reverse transcriptase polymerase chain reaction (RT-PCR)
analysis confirmed previous data (Fig. 4). Only CD34þ=
CD90þ cells were sorted and cultured for the experiments.
Cell differentiation was followed by observing the kinetics
of marker expression after sorting. Flow cytometry revealed
that the CD34þ=CD90þ population gradually lost positivity
for CD34 but not for CD90. Analyses performed at day 15 of
culture showed that the initial CD34þ=CD90þ cell population
comprised only approximately 2% CD34 positive elements
and 35% CD90 positive elements at this time (Fig. 5A); after
30 days of culture, the percentage of CD90 increased to 40%
(Fig. 5B). At this later time point, these cells acquired an
endothelial morphology and expressed high levels of endo-
thelial markers, including CD44þ=CD54þ (80%) and VEGFþ
(20%) (Fig. 5C, D). Isotypes and nonprobed cells, used as
controls, were negative.
We induced adipocyte differentiation also by adding dexa-
methasone, insulin, and IBMX to cultured cells, as specified
above. Cells cultured in this adipogenic medium differenti-
FIG. 3. Representative fluorescence-activated cell sorting performed at day 0 of culture. A significant number of
hADASCs are clearly positive for mesenchymal markers, including CD29 (72%), CD34 (25%), CD90 (30%), CD117 (7%), and
CD105 (5%), and for endothelial markers, including CD31 (6%), CD133 (8%), CD44=CD54 (5%), and Flk-1 (45%). Control
phycoerythrin-conjugated and fluorescein isothiocyanate–conjugated isotypes were negative.
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ated into adipocytes, as assessed using specific staining for
lipids.Diffuse adipocytedifferentiationwasobtainedwith this
method. After 72 to 96 h of digestion, approximately 80% of
cells differentiated into adipocytes containing a lipid content
positive for immunohistochemistry staining. The adipogenic
medium resulted in multivacuolar adipose cell formation
in a shorter time and with higher quantity than with the
medium of 20% FBS only.
In addition, we performed long-term cultures for 4 months
in which cells cocultured with 10% fibroblasts formed ag-
gregated centers at confluence and produced an extracellu-
lar matrix made of collagenic fibers (Fig. 6A). The tissue
continued to grow, forming a layer of human univacuolar
adipocytes. FACSorting identified a mixed population of
differentiated cells, including fibroblasts (10%), as assessed
according to specific antibodies (anti-fibroblast growth factor),
and univacuolar adipocytes. Analyses of the newly formed
tissue using histological staining revealed that adipose cells
surrounded a central area of fibrous connective fibers (colla-
genic fibers) (Fig. 6B). This extracellular matrix was strongly
positive to markers usually present in adipose tissue, includ-
ing type I collagen and fibronectin (Fig. 6C, D), and endo-
thelial markers, including VEGF, CD31 (platelet-endothelial
cell adhesion molecule-1) (Fig. 6E, F), and slightly positive
for VEGFR-2. In addition, adiponectin and PPARg were ex-
pressedmore than in human adult adipose tissue (Fig. 6G, H).
Discussion
In this study, we isolated and characterized stem and
progenitor cells from adult adipose tissue taken from mam-
mary (lipectomy) and abdominal (lipectomy and liposuction)
regions. We did not observe significant differences between
the two sites and demonstrated the ability of ex vivo expan-
ded human adipose tissue–derived stem cells to form adipose
tissue. The literature on stem cells has expanded tremen-
dously during the past 5 years, but studies have increased
more the understanding and theoretical capabilities of stem
cells rather than their effective tissue production and regen-
eration capacities.
One of the main challenges in medicine is regeneration
and repair of damaged tissues. The field of regenerative
medicine is growing, thanks to the implementation of stem
cell discoveries. Of great importance in this field is the use of
human stem cells rather than rat, mice, or other animal cells,
because they often differ, starting with their biology. Fur-
thermore, it is necessary to obtain a completely formed tissue
in vitro that is ready for use in human transplantation. In this
way, a sort of tissue factory for banking and quick use in re-
lationship to the patient’s demand could be obtained. The aim
of this study was to obtain an adipose tissue in vitro displaying
the same characteristics of human adipose tissue, through the
use of stem cells harvested from human fat, and suitable for
transplantation and use or banking. To obtain this result, we
designed three culture methods in an attempt to mimic the
embryology and physiology of human adipose tissue.
Adipose tissue is a greatly diffused tissue that can be har-
vested with minimal morbidity from humans. During life,
this tissue undergoes considerable changes in the number
FIG. 4. Representative figure of reverse transcriptase poly-
merase chain reaction showing mRNA transcript expres-
sion of CD90, CD34, CD44, CD54, and vascular endothelial
growth factor (VEGF) at 7, 14 and 30 days of culture.
FIG. 5. (A) Representative fluorescence-activated cell sort-
ing (FACS) of cells performed at day 15 of culture showing
that CD34þ=CD90þ cells are CD34þ only in 2% and CD90þ
in 35% of cells. (B) Representative FACS of cells performed at
day 30 of culture showing that the CD34þ=CD90þ cell pop-
ulation has lost its positivity for CD34 but not for CD90. (C)
Representative FACS of cells performed at day 30 of culture
showing CD34þ=CD90þ cell differentiation. These cells ac-
quire an endothelial morphology expressing high levels of
endothelial markers including CD44=CD54 (80%). (D) Re-
presentative FACS of cells performed at day 30 of culture
showing CD34þ=CD90þ cell differentiation. These cells ac-
quire an endothelial morphology expressing high levels of
endothelial markers including VEGF (20%).
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FIG. 6. (A) Differentiated cells that, after 4 months of culture, form aggregated centers (arrow) and produce an extracellular
matrix (original magnification,200). (B) Newly formed adipose tissue, stained with hematoxylin and eosin; adipose uni-
vacuolar cells (arrow) surround a central area made of fibrous connective (thick arrow) (original magnification, 100). Im-
munofluorescence images of the adipose tissue showing positivity for several specific antibodies for adipose matrix protein
including: (C) type I collagen (original magnification, 100); (D) fibronectin (arrow) (original magnification, 400). Im-
munofluorescence images of the adipose tissue showing positivity for specific endothelial markers including: (E) vascular
endothelial growth factor (arrow) (original magnification, 200); (E) CD31 (platelet-endothelial cell adhesion molecule-1)
(arrow) (original magnification,200). Immunofluorescence images of the adipose tissue showing positivity for adipose cells
markers, including: (F) adiponectin (original magnification,200) and (G) peroxisome proliferator-activated receptor gamma
(original magnification,400).
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of adipocytes it contains; the generation of new adipocytes
brings about this hyperplasia, which remodeling and ex-
pansion of the vasculature coordinates.21 This process is
mediated through differentiation of stem or progenitor cells
contained within the adipose tissue itself. Many researchers
have described the presence of a large population of stem or
progenitor cells within this tissue22 and have found that it
contains a multipotent cell population with properties simi-
lar to MSCs.23,24
In this study, we identified the presence of three cell
populations: stromal stem cells (c-Kitþ, CD34þ, CD45–),
mesenchymal stem or progenitor cells (CD90þ, CD34þ,
CD29þ, CD105þ, CD44þ, CD14–, CD45–), and endothelial
progenitor cells (CD44þ, CD54þ, VEGFþ and Flk-1þ). The
CD34 marker is an antigen on the surface of hematopoietic
progenitors,13 but it is well expressed on stromal stem cells,
fibroblasts, and endothelial progenitors.7 The combination of
CD34 with markers such as CD14 and CD45 (hematopoietic
progenitors), CD117, CD90 and CD105 (MSCs), and CD31 or
CD133 (endothelial progenitors) is a useful tool for the char-
acterization of stem progenitor cells. In addition, the finding
that these stem cells become CD34– shows that they are
different from circulating bone marrow–derived fibroblasts,
which remain positive for this surface marker antigen.25 Up
to now, CD90 (Thy1) has never been used for hADASc de-
tection, although it is a useful stem or progenitor cell marker.
The exact property and activity of CD90 has not been fully
elucidated. It has been speculated that it may exert a role in
cell-to-cell and cell-to-matrix interactions.
The relative expendability of adipose tissue, the ease with
which it can be obtained in large amounts with minimal risk,
and the possibility of easily removing contaminating mature
adipocytes lead to large yields. In addition, confluence is
achieved quickly for hADASCs, similar to MSCs.26 Studies
on stem cells from adipose tissue have focused on two main
directions: adipocyte differentiation27 and the osteogenic
potential of these cells.28
Adipose stem cells are often difficult to distinguished and
select from preadipocytes and the osteogenic lineage; al-
though it is possible, other stem cell sources are much more
affordable. In this regard, our research group has achieved
interesting results in bone regeneration19,20 and bone engi-
neering using dental pulp stem cells.29,30
Therefore, we think that the use of adipose stem cells is
mainly, although not only, devoted to the building of new
adipose tissue.
Another interesting point is that ADASs, like MSCs, are
able to suppress a mixed lymphocyte reaction in a dose-
dependent and time-dependent manner.31 In addition, it has
been demonstrated that clonally derived, multipotent cells
from adipose tissue are imunoprivileged in vitro or in vivo,32
suggesting that they, like MSCs, can be universal donor cells
with the ability to be used in allogenic transplantation, re-
ducing rejection risks.33 This is of paramount importance
because of its potentially widespread use; ADASs contain the
capability to functionally act as a vascular building block of
adipose and other tissues. We have focused our attention in
building a whole adipose tissue for quick use in transplanta-
tion. Although underappreciated, this is a valuable resource
for biotechnologies.23
Selected cells, under specific inductive stimuli, differentiate
into multivacuolar adipocytes, as confirmed using immu-
nohistochemical staining and RT-PCR for adiponectin and
PPAR-g. The strong PPARg expression suggests that this gene
has a predominant role during cell differentiation.34,35
Adipose tissue formation was achieved by adding 20%
FBS to cultures.19,20 FBS plays an essential role in differen-
tiation and proliferation.36
Our results are effectively in favor of its use. Although
many studies have been carried out on adipose stem cells, no
one has gained the result of obtaining an adult adipose tissue
for future clinical applications. The majority of studies have
been devoted to understanding the capability of these cells
to differentiate into various cell types or to hypothesize their
use in biotechnological or tissue engineering, although re-
sults were more hypothetical than realistic. The need for
adipose tissue in reconstructive medicine, plastic lipofilling,
and regenerative medicine increases daily.
In conclusion, our study has provided evidence that adi-
pose tissue represents an abundant source of stem cells capable
of forming, in vitro, an adipose tissue taht could be the criterion
standard for other studies, leading to its use in reconstructive
surgery applications and tissue-based clinical therapies.
References
1. Entenmann G, Hauner H. Relationship between replication
and differentiation in cultured human adipocyte precursor
cells. Am J Physiol 270, C1011, 1996.
2. Billings E Jr, May JW Jr. Historical review and present status
of free graft autotransplantation in plastic and reconstructive
surgery. Plast Reconstr Surg 83, 368, 1989.
3. Shenaq SM, Yuksel E. New research in breast reconstruction:
adipose tissue engineering. Clin Plast Surg 29, 111, 2002.
4. Mandrekas A, Zambacos G, Kittas C. Cyst formation after
fat injection. Plast Reconstr Surg 102, 1708, 1998.
5. Maillard G. Liponecrotic cysts after augmentation mam-
moplasty with fat injection. Aesth Plast Surg 18, 405, 1994.
6. Sommer B, Sattler G. Current concepts of fat graft sur-
vival: histology of aspirated adipose tissue and review of
the literature. Dermatol Surg 26, 1159, 2000.
7. Gimble J, Guilak F. Adipose-derived adult stem cells: isola-
tion, characterization, and differentiation potential. Cyto-
therapy 5, 362, 2003.
8. Hemmrich K, von Heimburg D, Rendchen R, Di Bartolo C,
Milella E, Pallua N. Implantation of preadipocyte-loaded
hyaluronic acid-based scaffolds into nudemice to evaluate po-
tential for soft tissue engineering. Biomaterials 26, 7025, 2005.
9. Kang SK, Putnam L, Dufour J, Ylostalo J, Jung JS, Bunnell
BA. Expression of telomerase extends the lifespan and en-
hances osteogenic differentiation of adipose tissue-derived
stromal cells. Stem Cells 22, 1356, 2004.
10. June ES, Lee TH, Cho HH, Suh SY, Jung JS. Expression of
telomerase extends longevity and enhances differentiation in
human adipose tissue-derived stromal cells. Cell Physiol
Biochem 14, 261, 2004.
11. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI,
Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH.
Human adipose tissue is a source of multipotent stem cells.
Mol Biol Cell 13, 4279, 2002.
12. Erickson GR, Gimble JM, Franklin DM, Rice HE, Guilak F.
Chondrogenic potential of adipose tissue-derived stromal
cells in vitro and in vivo. Biochem Biophys Res Commun 290,
763, 2002.
13. Halvorsen YD, Franklin D, Bond AL, Hitt DC, Auchter C,
Boskey AL, Paschalis EP, Wilkison WO, Gimble JM. Extra-
ADIPOSE TISSUE PRODUCTION FROM STEM CELLS 7
cellular matrix mineralization and osteoblast gene expres-
sion by human adipose tissue-derived stromal cells. Tissue
Eng 7, 729, 2001.
14. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk
PA, Zhu M, Dragoo JL, Ashjian P, Thomas B, Benhaim P,
Chen I, Fraser J, Hedrick MH. Comparison of multi-lineage
cells from human adipose tissue and bone marrow. Cells
Tissues Organs 174, 101, 2003.
15. Fischbach C, Spruss T, Weiser B, Neubauer M, Becker C,
Hacker M, Go¨pferich A, Blunk T. Generation of mature fat
pads in vitro and in vivo utilizing 3-D long-term culture of
3T3-L1 preadipocytes. Exp Cell Res 15, 54, 2004.
16. Patrick CW Jr, Zheng B, Johnston C, Reece GP. Long-term
implantation of preadipocyte-seeded PLGA scaffolds. Tissue
Eng 8, 283, 2002.
17. Neubauer M, Hacker M, Bauer-Kreisel P, Weiser B, Fisch-
bach C, Schulz MB, Goepferich A, Blunk T. Adipose tissue
engineering based on mesenchymal stem cells and basic fi-
broblast growth factor in vitro. Tissue Eng 11, 1840, 2005.
18. Hong L, Peptan IA, Colpan A, Daw JL. Adipose tissue en-
gineering by human adipose-derived stromal cells. Cells
Tissues Organs 183, 133, 2006.
19. Laino G, d’Aquino R, Graziano A, Lanza V, Carinci F, Naro
F, Pirozzi G, Papaccio G. A new population of human adult
dental pulp stem cells: a useful source of living autologous
fibrous bone tissue (LAB). J Bone Miner Res 20, 1394, 2005.
20. d’Aquino R, Graziano A, Sampaolesi M, Laino G, Pirozzi G,
De Rosa A, Papaccio G. Human postnatal dental pulp cells
co-differentiate into osteoblasts and endotheliocytes: a piv-
otal synergy leading to adult bone tissue formation. Cell
Death Differ 14, 1162, 2007.
21. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM,
Lowell BB, Langer R, Folkman MJ. Adipose tissue mass can
be regulated through the vasculature. Proc Natl Acad Sci
U S A 6, 10730, 2002.
22. Ailhaud G, Grimaldi P, Ne´grel R. Cellular and molecular
aspects of adipose tissue development. Annu Rev Nutr,
1992;12:207–233 Review.
23. Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an
underappreciated source of stem cell for biotechnology.
Trends Biotechnol 24, 150, 2006.
24. De Ugarte DA, Alfonso Z, Zuk PA, Elbarbary A, Zhu M,
Ashjian P, Benhaim P, Hedrick MH, Fraser JK. Differential
expression of stem cell mobilization-associated molecules on
multi-lineage cells from adipose tissue and bone marrow.
Immunol Lett 31, 267, 2003.
25. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Cir-
culating fibrocytes define a new leukocyte subpopulation
that mediates tissue repair. Mol Med 1, 71, 1994.
26. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble
JM, Bunnell BA. Biologic properties of mesenchymal stem
cells derived from bone marrow and adipose tissue. J Cell
Biochem 1, 1285, 2006.
27. Vermette M, Trottier V, Me´nard V, Saint-Pierre L, Roy A.
Fradette J. Production of a new tissue-engineered adipose
substitute from human adipose-derived stromal cells. Bio-
materials 28, 2850, 2007.
28. Hattori H, Sato M, Masuoka K, Ishihara M, Kikuchi T,
Matsui T, Takase B, Ishizuka T, Kikuchi M, Fujikawa K,
Ishihara M. Osteogenic potential of human adipose tissue-
derived stromal cells as an alternative stem cell source. Cells
Tissues Organs 178, 2, 2004.
29. Graziano A, d’Aquino R., Cusella-De Angelis MG, Laino G,
Piattelli A, Pacifici M, De Rosa A, Papaccio G. Concave pit-
containing scaffold surfaces improve stem cell-derived os-
teoblast performance and lead to significant bone tissue
formation. Plos ONE 2, e496, 2007.
30. Graziano A, d’Aquino R., Cusella-De Angelis MG, De
Francesco F, Giordano A, Laino G, Piattelli A, Traini T, De
Rosa A, Papaccio G. Scaffold’s surface geometry signifi-
cantly affects human stem cell bone tissue engineering. J Cell
Physiol 214, 166, 2008.
31. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet
C, Taureau C, Cousin B, Abbal M, Laharrague P, Penicaud
L, Casteilla L, Blancher A. Immunomodulatory effect of
human adipose tissue-derived adult stem cells: comparison
with bone marrow mesenchymal stem cells. Br J Haematol
129, 118, 2005.
32. Rodriguez AM, Pisani D, Dechesne CA, Turc-Carel C,
Kurzenne JY, Wdziekonski B, Villageois A, Bagnis C,
Breittmayer JP, Groux H, Ailhaud G, Dani C. Transplanta-
tion of a multipotent cell population from human adipose
tissue induces dystrophin expression in the immunocom-
petent mdx mouse. J Exp Med 2, 1397, 2005.
33. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC.
Suppression of allogeneic T-cell proliferation by human
marrow stromal cells: implications in transplantation. Trans-
plantation 15, 389, 2003.
34. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipo-
genesis in fibroblast by PPAR gamma 2, a lipid-activated
transcription factor. Cell 79, 1147, 1994.
35. Tontonoz P, Hu E, Spiegelman BM. Regulation of adipocyte
gene expression and differentiation by peroxisome pro-
liferator activated receptor gamma. Curr Opin Genet Dev 5,
571, 1995.
36. Garcia-Pacheco JM, Oliver C, Kimatrai M, Blanco FJ, Oli-
vares EG. Human decideual stromal cells express CD34 and
STRO-1 and a related bone-marrow stromal precursors. Mol
Hum Reprod 7, 151, 2001.
Address reprint requests to:
Prof. Gianpaolo Papaccio M.D., Ph.D.
Department of Experimental Medicine
Section of Histology and Embriology
TESLab
2nd University of Naples
via L. Armanni 5
80138 Naples, Italy
E-mail: gianpaolo.papaccio@unina2.it
Received: February 15, 2008
Accepted: April 14, 2008
8 D’ANDREA ET AL.
